MARKET

UNCY

UNCY

Unicycive Therapeutics Inc
NASDAQ
5.77
+0.18
+3.22%
After Hours: 5.79 +0.02 +0.38% 19:58 12/31 EST
OPEN
5.60
PREV CLOSE
5.59
HIGH
5.78
LOW
5.45
VOLUME
283.67K
TURNOVER
--
52 WEEK HIGH
11.00
52 WEEK LOW
3.710
MARKET CAP
124.01M
P/E (TTM)
-2.0234
1D
5D
1M
3M
1Y
5Y
1D
Guggenheim Keeps Their Buy Rating on Unicycive Therapeutics (UNCY)
TipRanks · 12/31/2025 08:25
De-Risked NDA Resubmission and TDAPA Tailwinds Support Buy Rating on Unicycive and OLC Commercial Upside
TipRanks · 12/30/2025 17:05
Unicycive resubmits NDA for hyperphosphatemia asset
Seeking Alpha · 12/29/2025 21:25
Unicycive Therapeutics resubmits NDA for oxylanthanum carbonate
TipRanks · 12/29/2025 12:10
Unicycive Therapeutics Has Resubmitted Its 505(b)(2) New Drug Application To FDA For Oxylanthanum Carbonate For Hyperphosphatemia In Patients With Chronic Kidney Disease On Dialysis
Benzinga · 12/29/2025 12:08
Unicycive Resubmits NDA for Oxylanthanum Carbonate to FDA
Reuters · 12/29/2025 12:05
UNICYCIVE THERAPEUTICS ANNOUNCES RESUBMISSION OF NEW DRUG APPLICATION (NDA) FOR OXYLANTHANUM CARBONATE (OLC)
Reuters · 12/29/2025 12:05
UNICYCIVE THERAPEUTICS INC - NDA SUBMISSION REVIEW EXPECTED WITHIN 6 MONTHS PER PRESCRIPTION DRUG USER FEE ACT
Reuters · 12/29/2025 12:05
More
About UNCY
Unicycive Therapeutics, Inc. is a biotechnology company developing treatments for kidney diseases. The Company's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.

Webull offers Unicycive Therapeutics Inc stock information, including NASDAQ: UNCY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UNCY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UNCY stock methods without spending real money on the virtual paper trading platform.